Acumen Biopharma LLC is categorized under Business Management Consultants in Pennington, NJ and active since 2011.
Acumen Biopharma LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Management Consultants business, which does work in the B2B market, and is classified as a Business Management Consultants, under code number 541611 by the NAICS.
If you are seeking more information, feel free to contact Daisy Rivera-Muzzio at the company’s single location by writing to 6 Howe Court, Pennington, New Jersey NJ 08534 or by phoning (973) 903-1809. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Acumen Biopharma LLC |
| Contact Person: | Daisy Rivera-Muzzio |
| Address: | 6 Howe Court, Pennington, New Jersey 08534 |
| Phone Number: | (973) 903-1809 |
| Website Address: | acumenbiopharma.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Management Consultants |
| SIC Code: | 8742 |
| NAICS Code: | 541611 |
| Share This Business: |
Acumen Biopharma LLC was started in 2011 to provide professional Business Management Consultants under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Daisy Rivera-Muzzio for inquiries that concern Acumen Biopharma LLC by calling the company number (973) 903-1809, as your correspondence is most welcome. Additionally, the physical location of the single location of Acumen Biopharma LLC can be found at the coordinates 40.296401,-74.773162 as well as the street address 6 Howe Court in Pennington, New Jersey 08534.
For its online presence, you may visit Acumen Biopharma LLC’s website at acumenbiopharma.com and engage with its social media outlets through on Twitter and on Facebook.